Condition
Hypertriglyceridemia
ClinicalTrials.gov condition label
Clinical trials
55 shownStandardized Large Yellow Tea Extract for Glucose and Lipid Metabolism in Overweight Adults With HypertriglyceridemiaNCT07840846 · 2026-09-01
NOT_YET_RECRUITINGWB-EMS Effects on Cardiometabolic Risk FactorsNCT07406191 · 2026-02-15
ACTIVE_NOT_RECRUITINGExploring Physical Exercise for the Regulation and Control of Metabolic Disorders in College Students.NCT06555159 · 2024-09-01
UNKNOWNResponse to an Intervention With Omega-3 (RIO - Study)NCT06538324 · 2024-07-30
COMPLETEDStudy of the Efficacy and Safety of EPA in Patients With Type-2 DiabetesNCT06129526 · 2023-12-01
UNKNOWNEffect of Silibinin(A) as a Potential Anti-obesity AgentNCT05069298 · 2023-01-12
UNKNOWNInsulin and Standard Management in Hypertriglyceridemic Acute PancreatitisNCT05487833 · 2022-11-01
UNKNOWNMN-001 in Non-alcoholic Fatty Liver Disease, Type 2 Diabetes Mellitus, and HypertriglyceridemiaNCT05464784 · 2022-08-22
ACTIVE_NOT_RECRUITINGOmega-3 Fatty Acid Dietary Intervention (O3DI)NCT05025943 · 2021-08-16
COMPLETEDAssess Efficacy and Safety of Epeleuton in Patients With Hypertriglyceridemia and Type 2 DiabetesNCT04365400 · 2020-10-13
TERMINATEDNutritional Transitions to More Plant Proteins and Less Animal Proteins: Understanding the Induced Metabolic Reorientations and Searching for Their Biomarkers (ProVegOmics)NCT04236518 · 2020-08-27
COMPLETEDImpacts of Lentils on Metabolism and InflammationNCT04283448 · 2020-05-22
COMPLETEDIntermittent Fasting in Hypertriglyceridemic Overweight or Obese SubjectsNCT04143971 · 2019-12-02
COMPLETEDAdiponectin, ICAM-1, VCAM-1 Levels and Metabolic Syndrome in Obese AdolescentsNCT05685017 · 2019-10-01
COMPLETEDImpacts of Aronia on Inflammation and the Gut MicrobiomeNCT04128839 · 2019-04-27
COMPLETEDTranslation of Pritikin Program to the CommunityNCT03929198 · 2018-09-27
COMPLETEDStudy of ISIS 703802 in Participants With Hypertriglyceridemia, Type 2 Diabetes Mellitus, and Nonalcoholic Fatty Liver DiseaseNCT03371355 · 2017-12-21
COMPLETEDSetmelanotide in a Single Patient With Partial LipodystrophyNCT03262610 · 2017-08-15
COMPLETEDThe Effect of Omega-3 FA on Hypertriglyceridemia in Patients With T2DM(OCEAN)NCT03120299 · 2017-05-01
COMPLETEDEffect of Totum-63, Active Ingredient of Valedia, on Glucose and Lipid Homeostasis on Subjects With PrediabetesNCT02868177 · 2016-10-01
COMPLETEDFeasibility and Acceptability of a Beverage Intervention for Hispanic AdultsNCT02911753 · 2016-06-01
COMPLETEDPK Study Comparing Metformin Eicosapentaenoate to a Combined Dose of Metformin Hydrochloride and Ethyl Ester EPANCT02113163 · 2014-03-01
COMPLETEDSimvastatin and Fenofibrate vs Simvastatin Alone in Patients With Type 2 Diabetes Mellitus and Acute Coronary SyndromeNCT02015988 · 2014-01-01
UNKNOWNImpact of Beans and Oats Snack Bar on Hypertriglyceridemic WomenNCT04966494 · 2013-10-05
COMPLETEDEffects of Acipimox on Mitochondrial Function in ObesityNCT01488409 · 2012-05-01
COMPLETEDGenetic Effect on Omega 3 Fatty Acids for the Treatment of Fatty Liver DiseaseNCT01556113 · 2012-03-01
COMPLETEDEffects of DPP-4 Inhibition on TriglyceridesNCT01527747 · 2012-01-01
SUSPENDEDFructose Consumption and Metabolic DysregulationNCT01445730 · 2011-08-01
COMPLETEDFish Oil Supplementation and Vascular Function in Hypertensive Patients With HypertriglyceridemiaNCT01480687 · 2011-05-01
UNKNOWNDiazoxide Choline Controlled-Release Tablet (DCCR) for Very High TriglyceridesNCT00973271 · 2011-03-01
WITHDRAWNEffect of Maraviroc on Metabolic Function in Obese Subjects (Phase I)NCT01133210 · 2011-01-01
COMPLETEDEfficacy Study of Diazoxide Choline to Treat HypertriglyceridemiaNCT01211847 · 2010-10-01
COMPLETEDThe Influence of Ritonavir, Alone and in Combination With Lopinavir, on Fenofibric Acid Pharmacokinetics in Healthy VolunteersNCT01148004 · 2010-05-13
COMPLETEDLovaza® and Microvascular Function in Type 2 DiabetesNCT00931879 · 2009-10-01
COMPLETEDBoosted Lexiva With Lovaza Adjunctive Therapy in Hypertriglyceridemic, HIV-Infected SubjectsNCT01010399 · 2009-09-01
COMPLETEDThe Effects of Omega-3 Fatty Acid (OMACOR) on the Low-density Lipoprotein (LDL) Sub-fraction in Type 2 Diabetic PatientsNCT00758927 · 2009-07-01
UNKNOWNChanges in Lipids and Safety of Raltegravir in HIV+ Patients With Hyperlipidemia While on Current Standard TherapyNCT00887653 · 2009-05-01
COMPLETEDEffect of Omega-3 Fatty Acid Supplementation on Hypertriglyceridemia in HIV-infected ChildrenNCT00691288 · 2008-06-01
TERMINATEDEffect of Omega-3 Fatty Acids Supplementation on Hypertriglyceridemia in Pediatric Patients With Obesity.NCT03216057 · 2008-05-20
COMPLETEDRegulation of Inflammatory Parameters by Telmisartan in Hypertensive PatientsNCT00560430 · 2007-11-01
COMPLETEDEffects of Omega-3 Fatty Acids on Markers of InflammationNCT01129050 · 2007-04-01
COMPLETEDOmega-3 Fatty Acids for High Triglycerides in HIV-infected PatientsNCT00346697 · 2006-10-01
COMPLETEDLaparoscopic Adjustable Gastric Banding With Truncal VagotomyNCT00329862 · 2006-05-01
TERMINATEDNovel Therapies for Metabolic Complications of LipodystrophiesNCT00457938 · 2006-04-01
COMPLETEDEffect of Tenofovir Disoproxil Fumarate on Lipid Levels in HIV Infected Adults on Stable Anti-HIV Drug TherapyNCT00109603 · 2005-05-01
COMPLETEDEffect of Soluble Fiber on Hypertriglyceridemia and Immune Profile in HIV-positive Individuals.NCT00540111 · 2005-03-01
COMPLETEDDiet, Exercise, Niacin, and Fenofibrate to Reduce Heart Disease Risk Factors in Individuals With HIV Lipodystrophy or DyslipidemiaNCT00246376 · 2004-01-01
COMPLETEDAcipimox to Improve Hyperlipidemia and Insulin Sensitivity Associated With HIVNCT00246402 · 2002-09-01
COMPLETEDEffect of Changing Diet on Fasting and Post Fat Load LipoproteinsNCT00593424 · 2002-08-01
COMPLETEDGenetic Determinants:Low HDL, High Triglycerides, ObesityNCT00049881 · 2002-04-01
COMPLETEDGarlic in Hyperlipidemia Caused by HAARTNCT00029250 · 2001-11-01
WITHDRAWNPharmacological Regulation of Fat Transport in Metabolic SyndromeNCT00632840 · 2001-06-01
COMPLETEDA Study on Efficacy and Safety of Topiramate in Treatment of Obese Subjects With DyslipidemiaNCT00231621 · 2001-05-01
TERMINATEDThe Effect of Fish Oil Plus Fenofibrate on Triglyceride Levels in People Taking Highly Active Antiretroviral Therapy (HAART)NCT00076518
COMPLETEDNiacin for Treatment of Elevated Cholesterol and Triglycerides in HIV-Infected PatientsNCT00046267
COMPLETEDCommon interventions
PlaceboDRUG8FenofibrateDRUG4PlaceboDIETARY_SUPPLEMENT4AcipimoxDRUG2NiacinDRUG2135 mg fenofibric acidDRUG1290 mg DCCRDRUG1435 mg DCCRDRUG1Aronia berry juiceDIETARY_SUPPLEMENT1atorvastatinDRUG1Atorvastatin and fenofibrateDRUG1BOSBDIETARY_SUPPLEMENT1CiprofibrateDRUG1ControlOTHER1ControlBEHAVIORAL1Control groupOTHER1Control group: Continuous aerobic physical exerciseBEHAVIORAL1Corn OilDIETARY_SUPPLEMENT1DHA-EPADIETARY_SUPPLEMENT1Diazoxide Choline Controlled-Release TabletDRUG1DietBEHAVIORAL1DietOTHER1Diet interventionOTHER1Dietary LentilBEHAVIORAL1Diets with either predominantly animal protein sources.BEHAVIORAL1
Leading sponsors
National Institute of Allergy and Infectious Diseases (NIAID)3Essentialis, Inc.2Montana State University2National Heart, Lung, and Blood Institute (NHLBI)2Washington University School of Medicine2Afimmune1Akcea Therapeutics1Baylor College of Medicine1Brown, Todd, M.D., Ph.D.1Central Carolina Surgery, PA1Eastern Virginia Medical School1Felizarta, Franco, M.D.1Hospital Infantil de Mexico Federico Gomez1Hospital Universitario Pedro Ernesto1Inje University1
Trial status mix
COMPLETED38
UNKNOWN7
TERMINATED4
ACTIVE_NOT_RECRUITING2
WITHDRAWN2
NOT_YET_RECRUITING1
SUSPENDED1
Phase mix
NA25
PHASE411
PHASE210
PHASE35
PHASE13
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.